MYL1 ‐Related Congenital Myopathy: Clinical, Genetic and Pathological Insights
Neuropathology and Applied Neurobiology · 2025
DOI: 10.1111/nan.70025 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropathology and Applied Neurobiology, 2025. Verfasst von Irene Madrigal und 19 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), …. Hauptthemen laut MEDLINE: Myopathies, Structural, Congenital, Myosin Light Chains, Myotonia Congenita. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundación Mutua Madrileña, Agència de Gestió d'Ajuts Universitaris i de Recerca.
Abstract (Originalsprache)
Congenital myopathies and congenital muscular dystrophies encompass heterogeneous clinical and genetic groups of disorders characterised by muscle weakness with antenatal or early postnatal onset. These conditions are categorised according to distinctive myopathological features and causative genes. Despite advances in diagnosis through massive parallel sequencing and progress in understanding the underlying pathogenesis, many aspects of these disorders remain poorly understood. MYL1 ‐related congenital myopathy is an ultra‐rare and severe condition, associated with a deficiency of essential/alkali light myosin and impaired development of fast‐twitch type II muscle fibres. This study aims to advance the understanding of the phenotype and pathogenesis of MYL1‐congenital myopathy. We analysed the clinical characteristics of two individuals harbouring three novel variants in the MYL1 gene. We conducted detailed genomic analysis and extensive studies on their muscles using histological, immunohistochemical, immunofluorescence, Western Blot and electron microscopy. Both individuals showed a very severe congenital myopathy, characterised by congenital hypotonia and weakness, requiring ventilatory and nutritional assistance. Muscle biopsy revealed dystrophic‐like or myopathic changes, with notable smallness of fast‐twitch type II fibres, often arranged around larger type I fibres, drawing a floret pattern. These fibres expressed developmental myosin and exhibited features of aberrant myofibrillogenesis. Type I myofibres exhibited correct sarcomere alignment, but like the small fast‐twitch fibres, both showed distorted cell organelles, vacuolar aggregates and membranous debris, indicating autophagic impairment. Our findings confirm that bi‐allelic MYL1 variants are associated with a severe congenital myopathy, characterised by a distinctive clinical and histopathological phenotype involving impaired type II fibre development. Additionally, our study reveals a role for MYL1 in the organisation and trophism of all muscle fibre types. Summary MYL1 biallelic variants cause severe congenital myopathy with early hypotonia and type II fibre hypotrophy. Muscle biopsy shows a distinct pattern, including floret‐like fibre arrangement. Findings suggest a broader role for MYL1 in fibre organisation and autophagy across muscle fibre types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Genetics Department, Hospital Clinic of Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Department of Paediatrics, Hospital Clinico Universitario de Valencia, Valencia, Spain.
- Department of Neonatology, BCNatal, Hospital Clinic Barcelona, Barcelona, Spain.
- Neuromuscular Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
- Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
ORCID-Profile: Nuria Muelas, Juan Jesus Vilchez, Daniel Natera-de Benito
Förderung
- Instituto de Salud Carlos III
- Fundación Mutua Madrileña
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Fundacion Isabel Gemio
Zitieren
APA
Madrigal, I., Villar-Vera, C., Arca, G., Expósito-Escudero, J., Rodríguez-Revenga, L., Piolatti-Luna, A., Muelas, N., Vilchez, R., Ciutad Celdran, M., Codina, A., Estévez-Arias, B., Carrera-Garcia, L., Ortez, C., Rodriguez-Carunchio, L., Sebastiani, G., Azorin, I., Nascimento, A., Jou, C., Vilchez, J. J., & Natera-de Benito, D. (2025). MYL1 ‐Related Congenital Myopathy: Clinical, Genetic and Pathological Insights. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.70025
Vancouver
Madrigal I, Villar-Vera C, Arca G, Expósito-Escudero J, Rodríguez-Revenga L, Piolatti-Luna A, et al. MYL1 ‐Related Congenital Myopathy: Clinical, Genetic and Pathological Insights. Neuropathology and Applied Neurobiology. 2025. doi:10.1111/nan.70025
BibTeX
@article{Madrigal2025,
author = {Madrigal, Irene and Villar-Vera, Cristina and Arca, Gemma and Expósito-Escudero, Jesica and Rodríguez-Revenga, Laia and Piolatti-Luna, Andres and Muelas, Nuria and Vilchez, Roger and Ciutad Celdran, Maria and Codina, Anna and Estévez-Arias, Berta and Carrera-Garcia, Laura and Ortez, Carlos and Rodriguez-Carunchio, Leonardo and Sebastiani, Giorgia and Azorin, Inmaculada and Nascimento, Andrés and Jou, Cristina and Vilchez, Juan Jesus and Natera-de Benito, Daniel},
title = {MYL1 ‐Related Congenital Myopathy: Clinical, Genetic and Pathological Insights},
journal = {Neuropathology and Applied Neurobiology},
year = {2025},
doi = {10.1111/nan.70025}
}
EUVIMED